Alloantigen Copy Number as a Critical Factor in RBC Alloimmunization.


Journal

Transfusion medicine reviews
ISSN: 1532-9496
Titre abrégé: Transfus Med Rev
Pays: United States
ID NLM: 8709027

Informations de publication

Date de publication:
01 2023
Historique:
received: 22 11 2022
revised: 19 12 2022
accepted: 20 12 2022
pmc-release: 01 01 2024
pubmed: 2 2 2023
medline: 21 3 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

RBC alloimmunization remains a significant barrier to ongoing transfusion therapy leading to morbidity, and in extreme cases mortality, due to delayed or insufficient units of compatible RBCs. In addition, the monitoring and characterization of alloantibodies, often with multiple specificities in a single patient, consumes substantial health care resources. Extended phenotypic matching has mitigated, but not eliminated, RBC alloimmunization and is only logistically available for specialized populations. Thus, RBC alloimmunization remains a substantial problem. In recent decades it has become clear that mechanisms of RBC alloimmunization are distinct from other antigens and lack of mechanistic understanding likely contributes to the fact that there are no approved interventions to prevent RBC alloimmunization from transfusion. The combination of human studies and murine modeling have identified several key factors in RBC alloimmunization. In both humans and mice, immunogenicity is a function of alloantigen copy number on RBCs. Murine studies have further shown that copy number not only changes rates of immunization but the mechanisms of antibody formation. This review summarizes the current understanding of quantitative and qualitative effects of alloantigen copy number on RBC alloimmunization.

Identifiants

pubmed: 36725483
pii: S0887-7963(22)00067-0
doi: 10.1016/j.tmrv.2022.12.009
pmc: PMC10023450
mid: NIHMS1870065
pii:
doi:

Substances chimiques

Isoantigens 0
Isoantibodies 0

Types de publication

Review Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-26

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL132819
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL150626
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

JCI Insight. 2018 Nov 15;3(22):
pubmed: 30429364
HLA. 2020 Aug;96(2):186-191
pubmed: 32388904
Transfusion. 2018 Jun;58(6):1536-1539
pubmed: 29516495
Nat Commun. 2021 May 11;12(1):2637
pubmed: 33976146
Front Immunol. 2021 Mar 12;12:629608
pubmed: 33777014
Genome Res. 2019 Mar;29(3):494-505
pubmed: 30659012
Transfusion. 2008 Jul;48(7):1318-24
pubmed: 18422846
Haematologica. 2020 Mar;105(3):539-544
pubmed: 32029505
Blood Adv. 2018 Nov 13;2(21):2986-3000
pubmed: 30413434
Immunohematology. 2017 Jun;33(2):56-59
pubmed: 28657763
Transfusion. 2010 Mar;50(3):642-8
pubmed: 19906034
Int J Pharm. 2013 Feb 25;443(1-2):39-49
pubmed: 23305866
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6724-8
pubmed: 2549544
Transfusion. 2023 Jan;63(1):239-248
pubmed: 36436200
Sci Rep. 2017 Jan 25;7:41120
pubmed: 28120936
Vox Sang. 2017 Feb;112(2):156-162
pubmed: 28052334
Br J Haematol. 2015 Jan;168(2):291-300
pubmed: 25256676
Blood Transfus. 2021 Jul;19(4):272-276
pubmed: 34704554
Front Immunol. 2020 Sep 25;11:584254
pubmed: 33101313
Transfusion. 2019 Oct;59(10):3243-3252
pubmed: 31403208
J Immunol. 1989 Aug 15;143(4):1239-44
pubmed: 2473123
Transfusion. 2018 Jul;58(7):1739-1751
pubmed: 29770450
Transfusion. 2022 May;62(5):948-953
pubmed: 35470900
Transfusion. 2019 Feb;59(2):448-453
pubmed: 30412270
J Immunol. 1983 Nov;131(5):2196-203
pubmed: 6631009
Vox Sang. 2021 Feb;116(2):234-238
pubmed: 32951225
Transfusion. 2006 Aug;46(8):1328-33
pubmed: 16934068
Am J Hematol. 2015 Aug;90(8):691-5
pubmed: 25963831
Transfusion. 2019 Mar;59(3):1118-1124
pubmed: 30548476
Transfusion. 2007 Dec;47(12):2197-201
pubmed: 17714422
Front Immunol. 2018 Nov 16;9:2516
pubmed: 30505302
Transfusion. 2014 Jan;54(1):86-97
pubmed: 23692415
J Immunol. 2017 Aug 1;199(3):1041-1050
pubmed: 28630094
Transfusion. 2006 Jun;46(6):1061-2
pubmed: 16734829
Clin Dev Immunol. 2013;2013:937846
pubmed: 23762099
J Immunol. 2017 Apr 1;198(7):2671-2680
pubmed: 28250159
Blood. 2013 Aug 22;122(8):1334-5
pubmed: 23970354
Blood. 2000 Dec 15;96(13):4011-9
pubmed: 11110668
Immunogenetics. 2000 Nov;52(1-2):53-62
pubmed: 11132157
Vox Sang. 2017 Aug;112(6):598-600
pubmed: 28597520
Br J Haematol. 2016 Oct;175(1):154-60
pubmed: 27340943
Blood Adv. 2021 Jan 26;5(2):527-538
pubmed: 33496748
Haematologica. 2015 Oct;100(10):e394-7
pubmed: 26185172
Blood. 2020 May 28;135(22):1983-1993
pubmed: 32266378
Blood. 2013 Sep 5;122(10):1793-801
pubmed: 23878139
Blood Transfus. 2019 Sep;17(5):368-377
pubmed: 30418129
Blood. 2013 Aug 22;122(8):1494-504
pubmed: 23801629
Genesis. 2004 May;39(1):1-9
pubmed: 15124222
Transfusion. 2013 Nov;53(11):2795-800
pubmed: 23480520
Transfusion. 2016 Apr;56(4):863-72
pubmed: 26643781
Transfusion. 2011 Aug;51(8):1732-9
pubmed: 21332724
Vox Sang. 2019 Jan;114(1):95-102
pubmed: 30421425
Blood. 2012 Feb 9;119(6):1566-9
pubmed: 22077064
Transfusion. 2017 Jan;57(1):82-92
pubmed: 27734515
Transfus Apher Sci. 2022 Oct;61(5):103447
pubmed: 35487873
Blood. 2012 Jun 7;119(23):5563-74
pubmed: 22490333
Transfusion. 2012 Dec;52(12):2620-30
pubmed: 22494154
Blood. 2008 Sep 15;112(6):2546-53
pubmed: 18535200
Blood Adv. 2018 Jan 23;2(2):105-115
pubmed: 29365318
Transfusion. 2017 Nov;57(11):2595-2608
pubmed: 28836263
Transfusion. 2006 Oct;46(10):1682-8
pubmed: 17002623
Blood Adv. 2018 Dec 26;2(24):3637-3647
pubmed: 30578281
Wellcome Open Res. 2017 Sep 13;2:84
pubmed: 29062914
Transfusion. 2022 Nov;62(11):2349-2362
pubmed: 36205403
Blood. 2016 Dec 29;128(26):3159-3168
pubmed: 27688803
Blood Transfus. 2014 Apr;12(2):244-9
pubmed: 24333082
Vox Sang. 2022 Nov;117(11):1332-1344
pubmed: 36121188
Vox Sang. 2016 Jul;111(1):79-87
pubmed: 26950259
Br J Haematol. 2016 Dec;175(5):956-966
pubmed: 27539877
Front Immunol. 2020 Jul 16;11:1516
pubmed: 32765523
Front Immunol. 2021 Jun 25;12:704072
pubmed: 34249009
Br J Haematol. 2018 Jun;181(5):672-681
pubmed: 29675950
Haematologica. 2023 Mar 01;108(3):905-908
pubmed: 36373252
Annu Rev Pathol. 2023 Jan 24;18:537-564
pubmed: 36351365
Transfusion. 2017 Mar;57(3):541-553
pubmed: 28164302
Proc Natl Acad Sci U S A. 1976 Oct;73(10):3671-5
pubmed: 62364
Front Immunol. 2018 Jun 11;9:676
pubmed: 29942300
Transfusion. 2020 May;60(5):1109-1110
pubmed: 32421874
Mol Immunol. 2009 Nov;47(1):64-70
pubmed: 19201475
Transfusion. 2014 Jan;54(1):179-89
pubmed: 23621760
Transfusion. 2005 Apr;45(4):520-6
pubmed: 15819672
Transfusion. 2003 Feb;43(2):173-6
pubmed: 12559012
J Immunol. 2014 Sep 15;193(6):2902-10
pubmed: 25122924
Transfus Med Hemother. 2014 Nov;41(6):453-61
pubmed: 25670933

Auteurs

Seema R Patel (SR)

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, USA.

Cheryl L Maier (CL)

Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.

James C Zimring (JC)

Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA, USA; Carter Immunology Center, University of Virginia, Charlottesville, VA, USA. Electronic address: jcz2k@virginia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH